Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-10-06

Clinical Trial Update: BradyXplore Phase II: Bradykinesia Feature Extraction System

View source ↗

Summary

Phase II trial evaluating the BradyXplore Bradykinesia Feature Extraction System for Parkinson's disease has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Great Lakes NeuroTechnologies Inc. | Conditions: Parkinson's Disease | Status: COMPLETED | Results posted: 2016-10-06